ATE473995T1 - Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung - Google Patents

Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung

Info

Publication number
ATE473995T1
ATE473995T1 AT02028323T AT02028323T ATE473995T1 AT E473995 T1 ATE473995 T1 AT E473995T1 AT 02028323 T AT02028323 T AT 02028323T AT 02028323 T AT02028323 T AT 02028323T AT E473995 T1 ATE473995 T1 AT E473995T1
Authority
AT
Austria
Prior art keywords
angiotensin
analogue
wound healing
tissue recovery
analogs
Prior art date
Application number
AT02028323T
Other languages
English (en)
Inventor
Kathleen Elizabeth Rodgers
Gere Stodder Dizerega
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Application granted granted Critical
Publication of ATE473995T1 publication Critical patent/ATE473995T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/14Angiotensins: Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
AT02028323T 1993-09-24 1994-09-19 Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung ATE473995T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12637093A 1993-09-24 1993-09-24

Publications (1)

Publication Number Publication Date
ATE473995T1 true ATE473995T1 (de) 2010-07-15

Family

ID=22424466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02028323T ATE473995T1 (de) 1993-09-24 1994-09-19 Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung

Country Status (9)

Country Link
US (1) US5716935A (de)
EP (2) EP1333034B1 (de)
JP (1) JPH09503205A (de)
AT (1) ATE473995T1 (de)
AU (1) AU697504B2 (de)
CA (1) CA2172494A1 (de)
DE (1) DE69435301D1 (de)
WO (1) WO1995008565A1 (de)
ZA (1) ZA947337B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902790A (en) * 1995-10-03 1999-05-11 Cytran, Inc. Pharmaceutical angiostatic dipeptide compositions and method of use thereof
US5955430A (en) 1993-09-24 1999-09-21 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
AU758319B2 (en) * 1994-11-14 2003-03-20 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
US5834432A (en) * 1995-06-06 1998-11-10 The University Of Southern California Use of angiotensin II Type 2 receptor agonists in tissue repair
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en) 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
US6110895A (en) * 1996-12-16 2000-08-29 University Of Southern California Method of promoting healing in skin grafts
US6335195B1 (en) 1997-01-28 2002-01-01 Maret Corporation Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
AU6650098A (en) * 1997-02-04 1998-08-25 University Of Southern California Method for accelerating healing of thermal injuries
US6248587B1 (en) 1997-11-26 2001-06-19 University Of Southern Cailfornia Method for promoting mesenchymal stem and lineage-specific cell proliferation
CA2315266C (en) 1997-12-12 2004-08-10 University Of Southern California Wound healing compositions
JP2002509077A (ja) 1998-02-09 2002-03-26 ユニヴァースティ オブ サザーン カリフォルニア 赤血球形成促進方法
US6455500B1 (en) 1998-03-10 2002-09-24 University Of Southern California Radiation therapy methods
CA2323237C (en) * 1998-03-10 2009-05-19 University Of Southern California Improved radiation therapy methods
US7173011B2 (en) 2000-11-20 2007-02-06 University Of Southern California Radiation therapy methods
AU3077299A (en) 1998-03-11 1999-09-27 University Of Southern California Method of promoting production of living tissue equivalents
AU759285B2 (en) * 1998-05-11 2003-04-10 University Of Southern California Methods to increase white blood cell survival after chemotherapy
US6762167B1 (en) 1998-05-11 2004-07-13 University Of Southern California Methods for treating a patient undergoing chemotherapy
US6916783B2 (en) 1998-07-13 2005-07-12 University Of Southern California Methods for accelerating bone and cartilage growth and repair
DE69911609T2 (de) 1998-07-13 2004-07-01 University Of Southern California, Los Angeles Verfahren zur beschleunigen den zuwachs und heilen von knochen und knorpel
AU755943B2 (en) 1998-08-13 2003-01-02 University Of Southern California Methods to increase blood flow to ischemic tissue
CA2364484A1 (en) * 1999-03-09 2000-09-14 University Of Southern California Method of promoting myocyte proliferation and myocardial tissue repair
EP1165099B1 (de) * 1999-03-23 2006-08-09 University Of Southern California Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
US7338938B2 (en) 1999-05-10 2008-03-04 University Of Southern California Methods for treating a patient undergoing chemotherapy
US6821953B1 (en) * 1999-12-16 2004-11-23 University Of Southern California Methods for treating and preventing damage to mucosal tissue
US6747008B1 (en) 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
WO2002043731A2 (en) 2000-11-30 2002-06-06 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
US7122523B2 (en) * 2001-05-01 2006-10-17 University Of Southern California Methods for inhibiting tumor cell proliferation
US20090227507A1 (en) * 2008-03-10 2009-09-10 University Of Southern California Angiotensin (1-7) Dosage Forms and Uses Thereof
EP2536422B8 (de) 2011-02-02 2023-06-21 University of Southern California Verfahren zur behandlung von diabetischen fussgeschwüren
US8557958B1 (en) 2012-06-18 2013-10-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of diabetes
US8633158B1 (en) 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
AU2014284496A1 (en) 2013-07-03 2016-01-21 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method for treating cognitive dysfunction
US9333233B2 (en) 2014-02-25 2016-05-10 Tarix Pharmaceuticals Ltd. Methods and compositions for the delayed treatment of stroke
US10183055B2 (en) 2014-07-21 2019-01-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
EP3171886A4 (de) 2014-07-21 2018-01-24 The Arizona Board of Regents On Behalf of the University of Arizona Ang-(1-7)derivat-oligopeptide und verfahren zur verwendung und herstellung davon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015629A (en) * 1989-06-26 1991-05-14 University Of Southern California Tissue repair

Also Published As

Publication number Publication date
ZA947337B (en) 1995-05-10
AU697504B2 (en) 1998-10-08
WO1995008565A1 (en) 1995-03-30
EP0745091A4 (de) 1998-05-20
EP1333034B1 (de) 2010-07-14
AU7836494A (en) 1995-04-10
DE69435301D1 (de) 2010-08-26
CA2172494A1 (en) 1995-03-30
EP0745091A1 (de) 1996-12-04
JPH09503205A (ja) 1997-03-31
US5716935A (en) 1998-02-10
EP1333034A1 (de) 2003-08-06

Similar Documents

Publication Publication Date Title
DE69435301D1 (de) Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung
DK0730465T3 (da) Anvendelse af angiotensin III og analoger dertil til vævsreparation
MX9703609A (es) Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
DE59305359D1 (de) Desodorierende kosmetische zubereitungen mit einem gehalt an di- oder triglycerinestern
ATE88899T1 (de) Wundheilung und knochenregeneration.
EA200000045A1 (ru) Косметическая композиция, содержащая отбеливающее и отшелушивающее средства
FI940932A0 (fi) Koostumuksia ja menetelmiä haavojen hoitamiseksi
ATE157251T1 (de) Verwendung von inositoltriphosphat zur behandlung von entzündungen
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
DE10075033I2 (de) substituierte Pyrazolyl-benzolsulfonamide zur Behandlung von Entzündungen.
MD1688G2 (ro) Benzotiofen, benzofuran şi indoltiazepinone, oxazepinone şi diazepinone, compoziţie farmaceutică, metodă de inhibare a aderării leucocitelor la celulele endoteliale pentru tratamentul proceselor inflamatorii şi metodă de tratament al mamiferelor infectate cu HIV infecţie .
ATE156363T1 (de) Wundheilung
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
DE59407098D1 (de) Verwendung von diglycerinestern gegen unreine haut
MX9301387A (es) Metodo y composicion para el tratamiento de osteoporosis.
DK0550719T3 (da) Neutralt implanteringssystem
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
ES2062664T3 (es) Poli(acido alfa-hidroxilacrilico) y derivados como compuestos activos antisarro en composiciones orales.
IL124431A0 (en) Sulfur containing dl-tert-butylphenol compounds useful as anti-inflammatory agents
BR0109139B1 (pt) composiÇÕes farmacÊuticas incluindo alginatos
BR9707266A (pt) Compostos dihidrobenzofurano úteis como agentes antiinflamatórios
ATE77954T1 (de) Pharmazeutisches praeparat zur behandlung von lebererkrankungen.
DK0569411T3 (da) Acylaminoalkylidenhydroxybiphosphonsyrer anvendelige til behandling af osteoartikulære sygdomme
MX9709983A (es) El uso de agonistas receptores tipo 2 de angiotesina ii en la preparacion de composiciones para la preparacion de tejidos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties